Imunon Inc (IMNN) is expecting -46.23% growth in the next quarter: What can investors do to maximize their returns?

Imunon Inc (NASDAQ: IMNN) kicked off on Friday, down -13.84% from the previous trading day, before settling in for the closing price of $0.56. Over the past 52 weeks, IMNN has traded in a range of $0.56-$3.65.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -20.00%. While this was happening, its average annual earnings per share was recorded 28.15%. With a float of $13.91 million, this company’s outstanding shares have now reached $14.62 million.

Considering the fact that the conglomerate employs 25 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 24.52%, operating margin of -572008.91%, and the pretax margin is -1231753.02%.

Imunon Inc (IMNN) Insider Activity

Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Imunon Inc is 4.89%, while institutional ownership is 10.89%. The most recent insider transaction that took place on Aug 20 ’24, was worth 29,480. In this transaction Director of this company bought 25,000 shares at a rate of $1.18, taking the stock ownership to the 25,597 shares. Before that another transaction happened on Aug 15 ’24, when Company’s President and CEO bought 25,000 for $0.98, making the entire transaction worth $24,500. This insider now owns 264,166 shares in total.

Imunon Inc (IMNN) Earnings and Forecasts

Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.27 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 28.15% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 28.83% during the next five years compared to 32.54% growth over the previous five years of trading.

Imunon Inc (NASDAQ: IMNN) Trading Performance Indicators

Take a look at Imunon Inc’s (IMNN) current performance indicators. Last quarter, stock had a quick ratio of 0.88.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.41, a number that is poised to hit -0.33 in the next quarter and is forecasted to reach -0.84 in one year’s time.

Technical Analysis of Imunon Inc (IMNN)

Compared to the last year’s volume of 0.19 million, its volume of 1.21 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 2.28%. Additionally, its Average True Range was 0.10.

During the past 100 days, Imunon Inc’s (IMNN) raw stochastic average was set at 3.32%, which indicates a significant decrease from 3.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 120.11% in the past 14 days, which was higher than the 80.80% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $0.8832, while its 200-day Moving Average is $0.9387. Nevertheless, the first resistance level for the watch stands at $0.6359 in the near term. At $0.7880, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.8759. If the price goes on to break the first support level at $0.3959, it is likely to go to the next support level at $0.3080. Should the price break the second support level, the third support level stands at $0.1559.

Imunon Inc (NASDAQ: IMNN) Key Stats

The company with the Market Capitalisation of 7.07 million has total of 17,542K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -18,620 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -4,060 K.

News Daemon
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.